Latest News

Mutant-Allele Tumor Heterogeneity (MATH) in head, neck squamous cell carcinoma patients is effective marker, along with HPV status, of improved patient outcome

Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient?s HPV status provides an effective indicator of improved patient outcome, according to research.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Consumer loyalty driven by aesthetics over functionality

  • When pursuing goals, people give more weight to progress than setbacks

  • Herd mentality: Are we programmed to make bad decisions?

  • Growing shortage of stroke specialists seen in U.S.

  • Electronic cigarettes facilitate smoking cessation, new evidence shows

  • Severely mentally ill criminals: who goes to prison and who goes to psych institutions?

  • Bugs life: The nerve cells that make locusts ?gang up?

  • Firearm violence trends in the 21st century

  • Personality outsmarts intelligence at school: Conscientiousness and openness key to learning

  • Women are more empathetic toward their partner than men

  •